Informações:
Sinopse
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episódios
-
![Episode 108: The BPLTTC Trial]()
Episode 108: The BPLTTC Trial
06/01/2021 Duração: 05minKazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.
-
![Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease]()
Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease
16/12/2020 Duração: 07minDr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.
-
![Episode 106: TCT Connect 2020]()
Episode 106: TCT Connect 2020
02/12/2020 Duração: 28minC. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.
-
![Episode 105: POPULAR TAVI]()
Episode 105: POPULAR TAVI
04/11/2020 Duração: 06minC. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.
-
![Episode 104: EMPEROR Reduced]()
Episode 104: EMPEROR Reduced
21/10/2020 Duração: 16minC. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.
-
![Episode 103: New ESC NSTEMI Guidelines]()
Episode 103: New ESC NSTEMI Guidelines
07/10/2020 Duração: 09minC. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more
-
![Episode 102: Innovation in Mitral Valve Repair]()
Episode 102: Innovation in Mitral Valve Repair
02/09/2020 Duração: 02minC. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.
-
![Episode 101: PARTNER 2A: 5-Year Outcomes]()
Episode 101: PARTNER 2A: 5-Year Outcomes
19/08/2020 Duração: 02minC. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.
-
![Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3]()
Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3
05/08/2020 Duração: 05minSuzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.
-
![Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients]()
Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients
22/07/2020 Duração: 02minC. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.
-
![Episode 98: #WomenAs1: The Battle for Gender Equality]()
Episode 98: #WomenAs1: The Battle for Gender Equality
15/07/2020 Duração: 06minRoxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.
-
![Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin]()
Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin
02/07/2020 Duração: 04minUsman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
-
![Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI]()
Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI
17/06/2020 Duração: 05minC. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.
-
![Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve]()
Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve
20/05/2020 Duração: 05minWhat are the respective values of FFR and OCT in guiding revascularization? C. Michael Gibson gets a primer from Francesco Burzotta.
-
![Episode 94: Wearables - The Future Is Now]()
Episode 94: Wearables - The Future Is Now
22/04/2020 Duração: 06minC. Michael Gibson connects with Sameer Mehta and Francisco Fernandez to hear how new tech is poised to disrupt medical care.
-
![Episode 93: Onyx ONE]()
Episode 93: Onyx ONE
17/04/2020 Duração: 07minC. Michael Gibson learns about the Onyx ONE trial from Stephan Windecker.
-
![Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin]()
Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin
01/04/2020 Duração: 05minC. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.
-
![Episode 91: Propensity Score-Matched Analysis]()
Episode 91: Propensity Score-Matched Analysis
18/03/2020 Duração: 04minMaurizio Taramasso walks C. Michael Gibson through randomized data focused on tricuspid valve disease.
-
![Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk]()
Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk
04/03/2020 Duração: 03minC. Michael Gibson hears from Ken Kozuma about the single-arm MODEL U-SES study.
-
![Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US]()
Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US
24/02/2020 Duração: 08minVinay Badhwar discusses new data from the STS Registry addressing volume/outcome relationships for mitral valve surgery.
